American Vanguard Corporation (AVD)

NYSE: AVD · Real-Time Price · USD
2.850
-0.110 (-3.72%)
At close: Apr 28, 2026, 4:00 PM EDT
2.850
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
-3.72%
Market Cap 81.34M
Revenue (ttm) 515.11M
Net Income (ttm) -49.88M
Shares Out 28.54M
EPS (ttm) -1.75
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 153,979
Open 2.960
Previous Close 2.960
Day's Range 2.830 - 2.980
52-Week Range 2.050 - 5.920
Beta 1.43
Analysts Strong Buy
Price Target 12.00 (+321.05%)
Earnings Date Mar 16, 2026

About AVD

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets synthetic, biological, and biorational products for agricultural, commercial, and consumer uses in the United States and internationally. The company synthesizes and formulates chemicals and ferments and extracts microbial products for crops, turf, ornamental plants, and human and animal health protection, such as insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liq... [Read more]

Sector Materials
Founded 1969
Employees 739
Stock Exchange NYSE
Ticker Symbol AVD
Full Company Profile

Financial Performance

In 2025, American Vanguard's revenue was $515.11 million, a decrease of -5.88% compared to the previous year's $547.31 million. Losses were -$49.88 million, -60.52% less than in 2024.

Financial Statements

Analyst Forecast

According to one analyst, the rating for AVD stock is "Strong Buy" and the 12-month stock price target is $12.0.

Price Target
$12.0
(321.05% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Top 3 Materials Stocks That May Rocket Higher This Month

The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.

Other symbols: MERCTANH
15 days ago - Benzinga

American Vanguard Earnings Call Transcript: Q4 2025

2025 saw lower sales but improved margins and cost controls, with new term loans providing stability. Cost-saving initiatives and new product launches are expected to drive growth, with 2026 guidance projecting higher EBITDA and positive free cash flow.

6 weeks ago - Transcripts

American Vanguard Announces Date of Full Year 2025 Earnings Release and Webcast Conference Call

NEWPORT BEACH, CA / ACCESS Newswire / March 13, 2026 / American Vanguard® Company announced today that it will report financial results for the full year ending December 31, 2025, on Monday, March 16,...

6 weeks ago - Accesswire

American Vanguard Corporation Announces Executive Appointment and Relocation of Global Headquarters

NEWPORT BEACH, CA / ACCESS Newswire / January 14, 2026 / American Vanguard Corporation (NYSE:AVD) has announced, the following change to its executive management team. Mike DiPaola has been appointed ...

3 months ago - Accesswire

American Vanguard Earnings Call Transcript: Q3 2025

Adjusted EBITDA surged over 350% year-over-year, with gross margin up 300 basis points and operating costs down 11% for the quarter. Full-year adjusted EBITDA guidance is $40M-$44M, with a focus on debt reduction and a robust product pipeline expected to drive future growth.

6 months ago - Transcripts

American Vanguard Reports Third Quarter 2025 Results

Quarterly Adjusted EBITDA of $8.2 million vs. $1.8 million in Q3 last year Maintains full year 2025 EBITDA Guidance of $40 million to $44 million NEWPORT BEACH, CA / ACCESS Newswire / November 10, 202...

6 months ago - Accesswire

American Vanguard Corporation Announces Extension to Existing Credit Agreement

Extension will provide the management team with an opportunity to provide a clearer picture of the Company's earnings power to the investment community NEWPORT BEACH, CA / ACCESS Newswire / August 19,...

9 months ago - Accesswire

American Vanguard Earnings Call Transcript: Q2 2025

Q2 2025 saw improved sales, nearly doubled adjusted EBITDA, and higher gross margins, driven by cost cuts and operational efficiencies. Management reaffirmed full-year guidance and expects continued margin expansion and debt reduction.

9 months ago - Transcripts

American Vanguard Reports Second Quarter 2025 Results

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--American Vanguard® Corporation, a diversified specialty and agricultural products company that develops, manufactures, and markets solutions for crop protection...

9 months ago - Business Wire

American Vanguard Announces Date of Second Quarter 2025 Earnings Release and Webcast Conference Call

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--American Vanguard® Corporation (NYSE: AVD) announced today it will release financial results for the second quarter of 2025 on Thursday, July 31, 2025, after th...

9 months ago - Business Wire

American Vanguard Announces Voting Results of 2025 Annual Meeting of Stockholders

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--American Vanguard Corporation (NYSE:AVD) announced the voting results from its Annual Meeting of Stockholders held on July 2, 2025. As to the first of three ini...

10 months ago - Business Wire

American Vanguard Earnings Call Transcript: Q1 2025

Q1 2025 revenue fell 14% year-over-year to $116 million, with adjusted EBITDA at $3 million. Cost controls and working capital improvements offset some headwinds from destocking, product removals, and market weakness. Full-year guidance was lowered, but signs of recovery are emerging.

11 months ago - Transcripts

American Vanguard Reports First Quarter 2025 Results

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--American Vanguard® Corporation (NYSE: AVD), a diversified specialty and agricultural products company that develops, manufactures, and markets solutions for cro...

11 months ago - Business Wire

American Vanguard Receives NYSE Notice Regarding Delayed 10-K Filing

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--On April 2, 2025 American Vanguard (NYSE: AVD) (the “Company”) received notice from the New York Stock Exchange (the “NYSE”) that the Company is not in complian...

1 year ago - Business Wire

American Vanguard Transcript: Gabelli Funds' 16th Annual Specialty Chemicals Symposium

New leadership is driving a transformation plan focused on operational efficiency, margin expansion, and growth in biologicals. The company targets a 15% EBITDA margin, improved plant utilization, and a stronger balance sheet, with 2025 guidance showing revenue and EBITDA growth.

1 year ago - Transcripts

American Vanguard Earnings Call Transcript: Q4 2024

2024 adjusted revenue and EBITDA declined year-over-year but met guidance, with significant non-recurring charges positioning the company for future growth. 2025 guidance anticipates modest sales and margin improvement, with transformation efforts and debt reduction as key priorities.

1 year ago - Transcripts

American Vanguard Reports Preliminary Results for Fourth Quarter & Full Year 2024

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--American Vanguard® Corporation (NYSE:AVD), a diversified specialty and agricultural products company that develops, manufactures, and markets solutions for crop...

1 year ago - Business Wire

American Vanguard Announces Date of Fourth Quarter 2024 Earnings Release and Webcast Conference Call

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--American Vanguard® Company (NYSE: AVD) announced today it will release financial results for the fourth quarter of 2024 on Friday, March 14, 2025, before the ma...

1 year ago - Business Wire

AMVAC®, DPH Biologicals™ Sign Regional Distribution Agreement

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--American Vanguard® Corporation today announced that its crop business unit, AMVAC®, entered into a regional distribution agreement with DPH Biologicals®, a lead...

1 year ago - Business Wire

American Vanguard CEO Dak Kaye to be Featured in Lake Street Capital Investor Forum

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--American Vanguard Corporation (NYSE:AVD) has announced that CEO, Douglas “Dak” Kaye, III, will be participating in an investor forum with Lake Street Capital an...

1 year ago - Business Wire

American Vanguard Reports Third Quarter 2024 Results

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--American Vanguard® Company, a diversified specialty and agricultural products company that develops, manufactures, and markets solutions for crop protection and...

1 year ago - Business Wire

American Vanguard Earnings Call Transcript: Q3 2024

Q3 sales and EBITDA declined year-over-year, mainly due to lower Aztec and Folex sales, but non-crop and Green Solutions segments showed strong growth. Full-year guidance for Adjusted EBITDA and sales is maintained, with optimism for a strong Q4 and ongoing business transformation benefits.

1 year ago - Transcripts

American Vanguard Withdraws Dacthal Registration

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--American Vanguard Corporation (NYSE: AVD) today announced that, following its decision in April 2024 to voluntarily stop sales of Dacthal herbicide products, th...

1 year ago - Business Wire

American Vanguard Reports Q2 2024 Results

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--American Vanguard Corporation (NYSE: AVD) today announced financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial Highlights...

1 year ago - Business Wire

American Vanguard Earnings Call Transcript: Q2 2024

Q2 2024 saw lower sales and margins amid a weak ag economy, prompting a leadership overhaul, cost-cutting, and a revised outlook. Full-year guidance was reduced, with a focus on transformation, liquidity, and a 15% EBITDA margin target by 2026.

1 year ago - Transcripts